Organon (OGN) Cash & Current Investments (2020 - 2026)

Organon (OGN) has reported Cash & Current Investments for 7 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments rose 104.02% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 104.02% YoY), while the FY2025 annual figure was $574.0 million, down 18.47% from the prior year.
• Cash & Current Investments came in at $1.1 billion for Q1 2026 at Organon, up from $574.0 million in the prior quarter.
• The five-year high for Cash & Current Investments was $1.1 billion in Q1 2026, with the low at $326.0 million in Q2 2023.
• Average Cash & Current Investments over 5 years is $623.5 million, with a median of $599.0 million recorded in 2025.
• The largest YoY upside for Cash & Current Investments was 392.2% in 2022 against a maximum downside of 50.5% in 2022.
• Year by year, Cash & Current Investments stood at $706.0 million in 2022, then decreased by 0.57% to $702.0 million in 2023, then increased by 0.28% to $704.0 million in 2024, then retreated by 18.47% to $574.0 million in 2025, then jumped by 94.43% to $1.1 billion in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $1.1 billion, $574.0 million, and $672.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.